date prepared august 28, 2015...date prepared august 28, 2015 name gregory m. miller ph.d. office...
TRANSCRIPT
Date Prepared August 28, 2015
Name Gregory M. Miller Ph.D.
Office Address Northeastern University
Bouve College of Health Sciences
Department of Pharmaceutical Sciences and Center for Drug Discovery
Mugar Hall Room 338
360 Huntington Ave., Boston, MA 02115
Home Address 21 Curtiss Circle, Sudbury, MA 01772
Work Phone (617)-373-6985
Cell Phone (508) 930-8027
Work Email [email protected]
Work FAX (617)-373-6985
Place of Birth Bronx, New York
Education
1986 B.A. Psychology Ithaca College, NY
1991 M.A. Psychology-
Neuropsychology
Queens College, City University of
New York
1993 Ph.D. Biomedical Sciences Mount Sinai School of Medicine, City
University of New York
Postdoctoral Training
09/93-01/94 Research Fellow
in Medicine, Division
of Endocrinology and
Metabolism
Neuroendocrinology
and Neurobiology of
Reproduction
Mount Sinai School
of Medicine,
New York, NY
01/94-01/97
Research Fellow in
Medicine,
Neuroendocrine Unit
Neuroendocrinology
and Pituitary Tumor
Biology
Massachusetts
General Hospital and
HMS, Boston, MA
01/10 Responsible Conduct of Research (RCR) HMS, Boston, MA
03/13 PRIM&R, Public Responsibility in Medicine Baltimore, MD
and Research; IACUC 101 Training and
IACUC Research Animal Oversight
2
Faculty Academic Appointments
01/97-05/97 Instructor Medicine Harvard Medical School
05/97-12/04 Instructor Psychiatry Harvard Medical School
01/05- 07/12
07/12- 08/14
Assistant Professor
Associate Professor
Psychiatry
Psychiatry
Harvard Medical School
Harvard Medical School
08/14 – Associate Professor Pharmaceutical Sciences Northeastern University
08/14 – Associate Scientist Center for Drug Discovery Northeastern University
08/14- 06/16 Visiting Assoc. Prof. Psychiatry Harvard Medical School
Appointments at Hospitals/Affiliated Institution
1/95 – 5/97 Assistant in
Biochemistry
Neuroendocrine Unit,
Medicine
Massachusetts General Hospital,
Boston, Massachusetts
9/14 – 6/16 Visiting Scientist Dept. of Psychiatry Beth Israel Deaconess Medical Center
Major Administrative Leadership Positions
1997-2005 Division Manager
Division of Neurochemistry
New England Primate Research
Center, Harvard Medical School
2006-2008 Acting Chair, Division of Neurochemistry New England Primate Research
Center, Harvard Medical School
2006-2014 Director, Primate Genetics Core New England Primate Research
Center, Harvard Medical School
2007-2011 Director of Research and Compliance
Mouse Behavioral Laboratory
New England Primate Research
Center, Harvard Medical School
2012-2014 Director, Summer Undergraduate and
Summer Veterinary Training Programs
New England Primate Research
Center, Harvard Medical School
Professional Service – Academic
2009 Member, Renovation Committee New England Primate Research
Center, Harvard Medical School
2010/2011
Chair, Search Committee - Genetics Faculty New England Primate Research
Center, Harvard Medical School
2012 Member, Animal Records Information
Technology Team
New England Primate Research
Center, Harvard Medical School
3
Professional Service – Academic, cont.
2013 Appointed - NEPRC IACUC New England Primate Research
Center, Harvard Medical School
2015 Honors Education Inquiry Group Northeastern University
2015 Graduate Student Committee
Department of Pharmaceutical Sciences
Northeastern University
2015 Department Chair Search Committee
Department of Pharmaceutical Sciences
Northeastern University
2015 Ph.D. Qualifying Exams
Department of Pharmaceutical Sciences
Northeastern University
2015 Ph.D. Thesis Proposal Defenses
Department of Pharmaceutical Sciences
Northeastern University
2015 Faculty Mentor for NU Masters Students
Department of Pharmaceutical Sciences
Northeastern University
2015 Capstone Project Supervisor
Department of Pharmaceutical Sciences
Northeastern University
Professional Service, National and International
2007-2014 Genomic Banking Consortium National Center for Research Resources
2007-2014 Genetics Consortium National Center for Research Resources
2008-2009 Member, Publications Committee College on Problem of Drug Addiction
2009-2012 Chair, Publications Committee College on Problem of Drug Addiction
2012-2016 Board Member, Board of Directors College on Problem of Drug Addiction
2012-2014 Nominations Committee College on Problem of Drug Addiction
2014- Senior Oversight, Pub. Committee College on Problem of Drug Addiction
Membership in Professional Societies
1992- Society for Neuroscience Member
2001- College on Problems of Drug Dependence Member
2005- Research Society on Alcoholism Member
2006- International Society of Psychiatric Genetics Member
2007- American Society for Pharmacology and Experimental Therapeutics Member
2013- Public Responsibility in Medicine and Research (PRIM&R) Member
4
Grant/Center Review Activities
2007 Grant Reviewer
October, 2007
Neurological Foundation of New
Zealand
2007-2008 The Mount Sinai Center for Personalized
Medicine Review Panel
Andrea and Charles Bronfman
Philanthropies, New York, NY
October, 2007 Center Reviewer
June, 2008 Center Reviewer
2008 Grant Reviewer
February, 2008
National Science Foundation, The
Hague, the Netherlands
2008 Grant Reviewer Netherlands Genomic Initiative
May, 2008 Ad hoc Reviewer
2008-2010 Grant Reviewer NSF
September, 2008 Ad hoc Reviewer
October, 2009 Ad hoc Reviewer
September, 2010 Ad hoc Reviewer
2009 B/START study Section NIDA/ NIH
March, 2009 Ad hoc Reviewer
2010 ZDA1 GXM-A (09) 1
March, 2010
NIDA/ NIH
Ad hoc Reviewer
2011 INIA WEST NIAAA/NIH
May, 2011 Reviewer
2011 INIA STRESS NIAAA/NIH
June, 2011 Reviewer
2011 ZAA1 GG (21) Ad hoc Reviewer
July, 2011 NIAAA/NIH
2012 Grant Reviewer Health Research Council of
February, 2012 New Zealand
2012 Harvard Catalyst Harvard Medical School
April, 2012 Reviewer
2013 ZRG1 NMB-A (02) S CSR
NIH Study Section
May/June, 2013
2013 Grant Reviewer The Leverhulme Trust
Visiting Professorship Grant London, UK
2014 ZRG1 MDCN-B(05) CSR
NIH Study Section
2015 ZRG1 MDCN-B(05) CSR
NIH Study Section
5
Editorial Activities (2007-)
2007, 2010, 2011 BMC Genomics
2007 American Journal of Primatology
2007, 2008, 2010 Molecular Psychiatry
2007 PNAS
2008 Archives of General Psychiatry
2008, 2009 Bioorganic and Medicinal Chemistry
2008 Journal of Molecular Biology
2008 Pharmacological Review
2008 BMC Neuroscience
2009 Journal of Lipid Research
2009 Molecular Pharmacology
2009 Biochemical Pharmacology
2010 Neuropharmacology
2010 Psychoneuroendocrinology
2010 Journal of Neural Transmission
2010 Human Genetics
2011 Schizophrenia Research
2011 Neuroscience & Biobehavioral Reviews
2011 Journal of Neuroimmune Pharmacology
2011 Psychopharmacology
2012, 2015 Neuropsychopharmacology
2012 Chemical Biology & Drug Design
2012 Progress in Neuro-Psychopharmacology & Biological Psychiatry
2012 Genes, Brain and Behavior
2012 Journal of Neurochemistry
2012 Journal of Medical Primatology
2012 Synapse
2013 Translational Developmental Psychiatry
2013 Pharmacogenetics and Genomics
2014 Journal of Pharmacology and Experimental Therapeutics
2014 International Journal of Neuropsychopharmacology
2014 Physiology and Behavior
2015 Scientific Reports/Nature Publishing Group
6
Other Editorial Roles
2009 Issue Editor, Genetic Tools for
Understanding the Primate Genome
Methods
2009-2012 Editor, News and Views Section Drug and Alcohol
Dependence
Awarded NIH Grants
1991-1994 Endocrinology Training Grant
NIDDK/ T32DK07645
Graduate Trainee
Terry Davies, MD (PI)
1994-1995 Endocrine Training Grant
NIDDK/ P32DK07028
Postdoctoral Trainee
Anne Klibanski, MD (PI)
1996-1997 Somatostatin Receptors in Pituitary Tumors
NIDDK/ NRSA F32DK09281
PI
1997-2006 Evaluation of novel cocaine medications
NIDA/R01 11558
Co-I; PI Bertha K. Madras
1998-2008 Molecular probes for cocaine recognition sites
NIDA/ R01 06303 (Merit Award to Bertha K. Madras)
Co-I (1998-2006); PI Bertha K. Madras
Managing PI (2006-2008; $731,859)
To explore neurochemistry of psychostimulant drugs of abuse and
therapeutics that target the brain monoamine transporters.
2004-2014 P51OD011103
(NEPRC Base grant)
NIH/OD/ORIP
Core Scientist; Jeffrey Flier PI
New England Primate Research Center Base Grant
Institutional support
2004-2010 Trace amine receptors in nonhuman primates
NIDA/ R01 016606
PI ($1,160,534)
To explore a newly-identified receptor family in primate brain.
7
Awarded NIH Grants, cont.
2006-2009 A monkey model of human mu-opioid receptor physiogenetics
NIDA/ R21 021180
PI ($457,399)
To explore comparable functionality of rhesus and human opioid receptor
polymorphisms.
2007-2010 Alcohol abuse pharmacogenomics: building naturalistic rhesus monkey
models
NIAAA/ R21 016194
PI ($443,823)
To assess novel polymorphisms and explore genotype/phenotype relationships
in rhesus monkeys related to human alcoholism.
2007-2010 Methamphetamine effects via Trace Amine Associated Receptor 1
NIDA/R21 022323
PI ($472,788)
To assess Trace Amine Associated Receptor 1 functionality with regard to mechanisms
of methamphetamine action in brain.
2008-2011 Neurogenetics of serotonin regulation: building naturalistic rhesus monkey
Models
NIMH/ R21 077995
PI ($429,413)
To assess neurogenetic effects of polymorphisms in serotonergic genes.
2009-2011 TAAR1 polymorphisms in rhesus monkeys
NIDA/ R03 025802
PI ($173,500)
To identify and characterize Trace Amine Associated Receptor 1 genetic
variants in rhesus monkeys and humans.
2009-2010 Alcohol abuse pharmacogenomics: building naturalistic rhesus monkey
Models
NIAAA/ R21 Supplement 016194-02S1
PI ($111,749)
To continue the productive research assessing novel polymorphisms and
exploring genotype/phenotype relationships in rhesus monkeys related to
human alcoholism.
8
Awarded NIH Grants, cont.
2009 Methamphetamine Effects via Trace Amine Associated Receptor 1
NIDA/ R21 Supplement 022323-02S1
PI ($11,267)
To fund a summer student, Kate Sullivan, to work on a project using Trace
Amine Associated Receptor 1 Knockout Mice.
2009-2014 Drug Abuse-related Neurobiology and Genetic Variance Modeled in
Rhesus Monkeys
NIDA/ K02 025697
PI ($615,275)
Independent Scientist Award (for salary support/career development)
2009-2014 Opioid Receptor Polymorphisms and Nonhuman Primate Models of Alcohol
Abuse
NIAAA/ R01 016828
Co-I; Donna Platt PI ($2.060,315)
To assess a novel polymorphism and explore naltrexone pharmacogenomics
in rhesus monkeys related to human alcoholism.
*This grant succeeds R21 021180 (GMM-PI)
2012-2014 Naltrexone and AIDS progression
NIDA/ 1R21DA034420
PI ($437,500.00)
To investigate Low Dose Naltrexone as a novel therapeutic intervention for
HIV using previously SIV-infected rhesus macaques.
2010-2015 Epigenetic Regulation of Serotonin: Relevance to HIV and Methamphetamine
Abuse
NIDA/ R21 030177 (3 yr RFP)
PI ($947,744 )
To investigate epigenetic mechanisms of serotonergic genes in normal and
SIV-infected rhesus monkeys.
2010-2015
Functional genetic evolution of human brain behavior
NIAAA/ 5R01AA19688
Co-I; Eric Vallender PI ($1,956,412)
To investigate functional polymorphisms in rhesus monkeys
9
Competitive Institutional Awards
2005-2007 NEPRC New Lab Start-up Package/ Promotion to Assistant Professor
New England Primate Research Center, Harvard Medical School
PI (two years of salary plus $50,000/year for two years)
To establish an independent laboratory at NEPRC.
2007-2009 Naturalistic modeling of alcoholism genotype/ phenotype relationships and
naltrexone pharmacogenomics in rhesus monkeys
NEPRC Pilot Project (competitive)
PI ($80,000 Direct Cost)
To establish a pharmacogenomic preclinical platform using rhesus monkeys
for medications development for alcoholism.
2009-2011 Development of a cognitive biomarker for alcoholism
NEPRC Pilot Project (competitive)
Originator, Co-I; Donna Platt PI ($100,000 Direct Cost)
Identify biomarkers of cognitive function in genetically-characterized alcohol-
drinking rhesus monkeys prior to and after alcohol exposure.
2010-2011 A marmoset model of methamphetamine-induced cognitive, motor and
neurological effects
NEPRC Pilot Project (competitive) PI ($40,000 Direct Cost)
To investigate behavioral effects of methamphetamine mediated by Trace
Amine Associated Receptor 1.
2015- Unrestricted Faculty Research Funds
PI ($187,000)
These funds were gifted to me from Harvard University and were transferred
to Northeastern University for my professional use.
Funding of Student Mentees
2006 Irene and Eric Simon Brain Research Foundation Summer
Fellowship to fund Liz Calder, undergraduate student
“A monkey model of mu-opioid receptor physiogenetics”
2007-2012 Supervision and training of one undergraduate summer student each year funded
through the Department of Psychology University of Massachusetts, Amherst MA
2009 NIH R21 Supplement 022323-02S1
Funding for Kate Sullivan, undergraduate student
“Methamphetamine Effects via Trace Amine Associated Receptor 1”
10
Funding of Student Mentees, cont.
2011 College on Problems of Drug Dependence Travel Award
NIDA Mini-convention - Frontiers in Addiction Research
Kiran Akila, foreign student from India
2015 Northeastern University Provost Undergraduate Research and Creative Endeavors
Award to fund Paige Dickson, undergraduate student
“Elucidation of the chemically-induced methamphetamine immune response and
its potential mediation by a receptor target, Trace Amine Associated Receptor 1"
Addiction Sciences Lab, Miller PI, Northeastern University ($2,625)
2015 Northeastern University
Undergraduate Honors Program Early Research Assistantship, Inaugural.
Only faculty member awarded two awards
Selected students: Nina L Tamashunas, Kevin S Freeman
Addiction Sciences Lab, Miller PI, Northeastern University ($1000 each)
2015 Northeastern University Scholars Independent Research Fellowships (SIRFs)
To fund two Honors Scholars Students under my mentorship
Jared Ontko and Cindy Wu
"Central and microbiomic circadian disruptions during finals week: How
biological clocks in the gut and brain interact to effect cognitive performance
during diet change and sleep deprivation.” ($10,000)
2015 Northeastern University Scholars Independent Research Fellowships (SIRFs)
To fund two Honors Scholars Students under my mentorship
Kristen Brown and Christine Boutros
"Exploring co-use of marijuana and alcohol (“crossfading”): order effects of
marijuana constituents on ethanol self-administration in a mouse model."
($10,000)
2015 Northeastern University
Undergraduate Honors Program Early Research Assistantship, Summer 2015.
Two awards
Selected students: Nicholas Mortillaro, Lauren Abbott($1000 each)
2015 Nu Rho Psi Undergraduate Research Grant – 1 of 2 National Awards -
Kristen Brown, Sophomore, Honors Scholars Undergraduate, Behavioral
Neuroscience; and Christine Boutros, Sophomore, Honors Scholars Undergraduate,
Behavioral Neuroscience
"Exploring co-use of marijuana and alcohol (“crossfading”): order effects of
marijuana constituents on ethanol self-administration in a mouse model"
($400)
11
Unfunded and/or In Submission NIH Grants
2014 2R01DA011558-10A1 (MPI)
Novel psychostimulant drugs of abuse: behavior, biology, pathology.
Miller PI; Madras PI
Impact Score: 44, Percentile Score: 46.0
2014 1R21DA036708-01
Immunological actions of methamphetamine via trace amine associated receptor 1
Miller-PI
Impact Score: 58
2014 1R01AA021189-01A1
Trace amine associated receptor 1 in alcohol behaviors and treatments
Miller-PI
Impact Score: 49
2014 TAAR1-Cannabinoid Receptor Signaling Interactions in Drug Abuse
R21 submission 10/16/14 not discussed
Resubmitted 5/15
2015 Alternative REST Splicing and Neural Gene Expression
R21 submission 2/19/15 not discussed
2015 Alternative Splicing of REST in Neuroepigenetics
R01 submission 6/3/15
Teaching and Training
Teaching of Students in Courses
1988, 1989 Psychology 101
Undergraduate
City University of New York
1998 Substance Abuse: Addictive Process
ABS PS 521 M.O.
4th year medical students
Harvard Medical School
2014 PHSC6300 11556 Pharmaceutical Science
Seminar SEC 01 - Fall 2014
Graduate
Northeastern University
12
Teaching of Students in Courses, cont.
2014 PHSC6984 17881 Pharmaceutical Science
Research SEC 05 - Fall 2014
Graduate
Northeastern University
2015 PHSC6300 31639 Pharmaceutical Science
Seminar SEC 01 - Spring 2015
Graduate
Northeastern University
2015 PHSC6984 37349 Pharmaceutical Science
Research SEC 03 - Spring 2015
Graduate
Northeastern University
2015 PMCL6261 36820 Pharmacology 2 SEC 01 -
Spring 2015
Graduate
Northeastern University
2015 PHSC4502 50013 Pharmacology/Med
Chemistry 2 SEC 01 - Summer Full 2015
Undergraduate
Northeastern University
2015 PHSC 4501 – Pharmacology/Medicinal
Chemistry 1 SEC 01 – Fall 2015
Undergraduate
Northeastern University
Teaching of Students (Assistantships, Lecture Series)
1991-1992 Neuroendocrinology
Arthur M. Fishberg Center for
Neurobiology
Mount Sinai School of Medicine, New York,
NY
2003, 2005 Cell Biology of Addiction
Cold Spring Harbor
Course Assistant
2008 Beth Israel Deaconess Medical
Center Psychiatry Residents
training in Neuroscience
Department of Psychiatry
Residents
Initiated and organized NEPRC tour and lecture
series presented by NEPRC Neuroscience
faculty. Presented 1 lecture: Comparable
Functional Polymorphisms in Rhesus Monkey
and Human Neuropsychiatric Genes
13
Teaching in Continuing Medical Education Courses
1997 Neurobiology of Addiction Boston, MA
CME: Treating the Addictions
Cambridge Health Alliance and Department of
Psychiatry, Harvard Medical School
2008 The Neurobiology and Genetic Susceptibility of
Addiction
Boston, MA
CME: Treating the Addictions.
Cambridge Health Alliance and Department of
Psychiatry, Harvard Medical School
Ratings by 661 Attendees (mean):
Teaching ability: 3.56/4
Level of Knowledge: 3.84/4
The objective was met: 3.55/4
New Concepts Learned: 3.56/4
Training and Mentorship in Research
Mentoring of Postdoctoral Research Associates
From 1996-2005, I had the opportunity to mentor postdoctoral research associates working under my
supervisory assignment:
1996-1997 Mentoring of an Endocrinology Resident:
Joseph Pinzone, MD
Neuroendocrine Unit, MGH
Daily mentorship, 1 year
1997-1998 Mentoring and training of an Assistant Professor:
Larry Gracz, PhD
Division of Neurochemistry, NEPRC
Daily mentorship, two
consecutive summers
1997-2005 Mentoring of Postdoctoral Fellows:
Richard De La Graza, PhD
Martin Goulet, PhD
Jeffrey Brown, PhD
Servet Yatin, PhD
Danqing Xiao, PhD
Christopher Vericco, PhD
Amy Jassen, PhD
Over 8 years in the
Division of
Neurochemistry and
Instructor in Psychiatry, I
mentored seven
postdoctoral fellows; daily
mentorship. All seven
have co-published
manuscripts with me.
14
Mentoring of Postdoctoral Research Associates, cont.
Mentored postdoctoral research associates funded under my NIH grants:
2005-2013 Guo-lin Chen, Ph.D.
Research Assistant Professor, Department of Pharmaceutical science and Center
for Drug Discovery, Northeastern University
Instructor in Psychiatry (promoted 12/13) Division of Neuroscience, NEPRC,
HMS; Postdoctoral Fellow, Miller Lab, NEPRC 2005-2013
15 publications in my lab/ 10 are first authorship
Co-I and major contributor; R21 DA030177 Epigenetic Regulation of Serotonin:
Relevance to HIV and Methamphetamine Abuse, 6/10-2/14
Winner of Best Paper in Neuroscience at NEPRC - 2012 Winner of the 3rdt
Annual Roger T. Kelleher Award for Excellence in Neuroscience and Behavior
for: Chen G-L and Miller GM. Advances in Tryptophan Hydroxylase-2 Gene
Expression Regulation: New Insights into Serotonin-Stress Interaction and
Clinical Implications. American Journal of Medical Genetics Part B:
Neuropsychiatric Genetics. Mar;159B(2):2012, 152-71.
2005-2012 Zhihua Xie, Ph.D.
Independent Consultant, Biobanking Strategies
Research Associate, Division of Neuroscience, NEPRC
Postdoctoral Fellow, Miller Lab, NEPRC 2005-2009
11 publications in my lab/ 7 are first authorship
Best paper in Neuroscience at NEPRC: 2010 Winner of the 1st Annual Roger T.
Kelleher Award for Excellence in Neuroscience and Behavior for: Xie Z and
Miller GM. A Receptor Mechanism for Methamphetamine Action in Dopamine
Transporter Regulation in Brain. J. Pharmacol. Exp. Ther. 2009;330(1):316-25.
2006-2009
Eric J. Vallender, Ph.D.
Associate Professor, University of Mississippi Medical Center, 2015
Assistant Professor in Psychiatry 2012, Division of Neuroscience, NEPRC, HMS
Postdoctoral Fellow, Miller Lab, NEPRC 2005-2009
Instructor, Miller Lab, NEPRC 2009-2012
Promotion to Assistant Professor 6/12, Harvard Medical School
>20 publications 2005-2013; Awarded NRSA MH082507, Modeling the
Neurogenetics of Serotonin Regulation Awarded R01 AA019688 Functional
Genetic Evolution of Human Brain and Behavior, 8/10-7/15
Vallender-PI; Miller Co-I
Selected as an NEPRC “Super-Instructor” following a national search and given an
extensive laboratory start-up package
15
Mentoring of Postdoctoral Research Associates, cont.
2009-2010 Spencer Lynn, Ph.D.
Research Assistant Professor,
Northeastern University, Dept. Psychology
1 publication in my lab
Awarded R01 MH093394-01 The Utility of Threat Detection in Generalized Social
Anxiety Disorder: Score 14, percentile 6.0
Mentoring of Post-Bachelorette Research Technicians
Reflects my strong commitment to the academic advancement of post-bachelorette young adults who
were hired as research technicians in my lab.
Jacob Bendor, PhD Postdoctoral Fellow, UCSF Neurology
Trained at Rockefeller University with Paul Greengard
Summer student in my lab 2001 and 2002; Research Technician I in my lab 2003 and 2004
Publication: Miller GM, Bendor J, Tiefenbacher S, Yang H, Novak M, Madras BK. A Mu-opioid
receptor single nucleotide polymorphism in rhesus monkey: Association with stress response and
aggression. Molecular Psychiatry 2004; 9(1):99-108.
Sara Hakim Graduate Student, The Albert Einstein College of Medicine
Summer student in my lab 2005 and 2006; Research Technician I in my lab 2007 and 2008
Publications: Chen GL, Novak MA, Hakim S, Xie Z, Miller GM. Tryptophan hydroxylase-2 gene
polymorphisms in rhesus monkeys: association with hypothalamic-pituitary-adrenal axis function
and in vitro gene expression. Molecular Psychiatry, 2006;11(10):914-28; Vallender EJ, Priddy CM,
Hakim S, Yang H, Chen G-L, Miller GM. Functional variation in the 3’ UTR of the serotonin
transporter in human and rhesus macaque. Genes, Brain and Behavior 2008;7(6):690-7.
Cassandra Priddy Graduate Student, Carnegie Mellon University
Research Technician I 2006-2007; Research Technician II 2007-2008
Publications: Vallender EJ, Priddy CM, Chen G-L, Miller GM. Human Expression Variation in the
mu Opioid Receptor is Paralleled in the Rhesus Macaque. Behavior Genetics, 2008;38(4):390-395;
Vallender EJ, Priddy CM, Hakim S, Yang H, Chen G-L, Miller GM. Functional variation in the 3’
UTR of the serotonin transporter in human and rhesus macaque. Genes, Brain and Behavior
2008;7(6):690-7.
Caroline Sweeney Graduate Student University of Massachusetts
Research Technician 2011-2013
Lisa Ogawa Graduate student, Yale University
Research Technician 2012-2014
Publication: Large-scale polymorphism discovery in macaque G-protein coupled receptors. BMC
Genomics. 2013 Oct 11;14:703.
16
Mentoring of Undergraduate Students
1997-2005 Supervision and training of undergraduate summer
students in the Division of Neurochemistry
New England Primate Research Center Summer
Undergraduate Training Program (SUTP)
Over 8 years, I supervised
2-4 students per summer.
2005-2013 Supervision and training of undergraduate summer
students in my lab
New England Primate Research Center Summer
Undergraduate Training Program (SUTP)
>30 undergraduate
summer students trained in
my lab over this period,
averaging 6-7/summer
2014-2015 Originated a research mentorship program for undergraduate students
Program overview: I initiated a “skunkworks” educational program on my own initiative and time,
born out of my interest in recruiting students into biomedical research. Students were first taken
through EH&S training and introduced to how to search the biomedical literature and use library
resources. After studying and commenting on three review papers that I had written on one of the
receptors that we study, students were granted access to a community database of electronic folders
containing scientific literature by topic – centered on the concepts they were introduced to in the
reviews - as a guide to help them develop their interests. Students were invited to add relevant
literature to any folder, or to create their own folder. Students were assisted in gravitating towards an
interest focus and in partnering with others who share a similar interest. The process created several
“think tanks” where collaborative ideas got generated, fostered by Journal Club-like meetings in the
evenings in Snell library, which students attended and participated in voluntarily. In doing so students
built enthusiasm, comradery and a team mentality. Throughout this process, students followed a
“graphic syllabus” that I created which instructs on how one goes about getting involved in scientific
research of highest impact and meaning. Concurrent with these activities, students were introduced to
working in the lab. Each student learned basic cell culture and many learned basic molecular biology
skills. In addition to learning the specific laboratory techniques, students were exposed to a spectrum
of knowledge and skills related to productive lab work, research methods, data presentation, ethics and
personal integrity. Most notably, students learned how to work collaboratively together, developed
laboratory skills and were introduced to issues related to the use of animal models in biomedical
research.
Outcomes:
Students fulfilled all EH&S requirements
Students were mentored in hypothesis generation and study design
Students were taught laboratory techniques and methodologies
Students were introduced to Research Ethics and a related mandate - a focus on animal research
ethics was used to teach skills related to defending personal opinions with facts
Students ran journal clubs at night that introduced the structure of the scientific manuscript and
the research grant, as well as manuscript reviews related to their proposed projects
Students recruited others into their team who were interested in the topic they were covering
Students developed a long-term mentor/mentee relationship
See “Funding of Student Mentees” above.
See graphic syllabus
http://www.northeastern.edu/bouve/assets/uploads/2014/10/Graphic-Syllabus-for-students.pdf
17
Local, Regional, National and International Invited Scientific Presentations
Presentation within my local institution
2000 Molecular Approaches to Attention Deficit Hyperactivity Disorder
NEPRC Summer Internship Program
New England Primate Research Center, Southborough, MA
2002 Genes and Drug Addiction
NEPRC Summer Internship Program
New England Primate Research Center, Southborough, MA
2002 Point mutations of the human dopamine transporter reveal differential binding of an
amine and a nonamine ligand
Neuroscience Seminar Series
McLean Hospital, Belmont, MA
2003 Genetic Diversity of Drug Targets in the Brain
NEPRC Summer Internship Program
New England Primate Research Center, Southborough, MA
2004 Genetic Variations and Phenotypic Associations Common to Rhesus Monkeys and
Humans
New Faculty Search Seminar
New England Primate Research Center, Southborough, MA
2005 Rhesus Monkey Models in Neurobiology, Neuropsychiatry and AIDS
Boston University-NEPRC symposium
New England Primate Research Center, Southborough, MA
2005 Naturalistic Modeling of Human Functional Polymorphisms in Rhesus Monkeys
Research Symposium
New England Primate Research Center, Southborough, MA
2008 What are the Roles of Trace Amine-Associated Receptor 1 in Primates?
Division of Behavioral Biology, NEPRC
New England Primate Research Center, Southborough, MA
2008 Trace Amine Receptor 1 in Brain Monoaminergic Systems
Division of Comparative Pathology
New England Primate Research Center, Southborough, MA
2008 Trace Amine Associated Receptor 1 in Brain Monoaminergic Systems
Neuroscience Seminar Series
McLean Hospital, Belmont, MA
18
2008 The Neurobiology and Genetic Susceptibility of Addiction
NEPRC Summer Internship Program
New England Primate Research Center, Southborough, MA
2008 Comparable Functional Polymorphisms in Rhesus Monkey and Human
Neuropsychiatric Genes
The Behavioral Genetics Laboratory
McLean Hospital, Belmont, MA
2011 Drug addiction research at the New England Primate Research Center
Division of Primate Resources Animal Care Staff
New England Primate Research Center, Southborough, MA
2011 The Biogenic Amine/Amphetamine Receptor TAAR1: What’s It Doing in Brain
Monoaminergic Systems?
Neuroscience Seminar Series
McLean Hospital, Belmont, MA
2013
Models of polygenetic psychiatric and addictive disorders
Grand Rounds
Center for Addiction Medicine
Massachusetts General Hospital, Boston, MA
Regional
2008 Trace Amine-Associated Receptor 1 in Brain Monoaminergic Systems
Invited Speaker, Boston University Medical School, Boston, MA
2009 The Neurobiology and Genetic Susceptibility of Addiction
Invited Speaker
Summer Undergraduate Research Fellowship (SURF) Program Seminar Series
The Massachusetts College of Pharmacy and Health Sciences, Boston, MA
2010 The Role of TAAR1 in Monoamine Transporter Regulation and Methamphetamine
Action
Invited Speaker, Center for Drug Discovery Annual Symposium
Northeastern University, Boston, MA
2013 Trace Amine Associated Receptor 1 in the Monoamine System and its Role in
Modulating the Effects of Drugs of Abuse
Invited Speaker, Department of Pharmaceutical Sciences
Bouvé College of Health Sciences
Northeastern University, Boston, MA
2014 TAAR1 and Drugs of Abuse
Invited Speaker, Center for Drug Discovery Annual Symposium
Northeastern University, Boston, MA
19
National
1999 Point mutations in the human dopamine transporter reveal differential binding of
an amine and a non-amine ligand
Oral presentation/ selected abstract
Society for Neuroscience Annual Meeting, Miami Beach, Florida
2000 Single Nucleotide Polymorphisms Distinguish Multiple Dopamine Transporter
Alleles in Primates: Implications for Association With ADHD and Other
Neuropsychiatric Disorders
Oral presentation/ selected abstract
Society for Neuroscience Annual Meeting, New Orleans, Louisiana
2001 Genetic Diversity of Drug Targets in the Brain: Relevance to Drug Response?,
Oral presentation/ selected abstract
College on Problems of Drug Dependence Annual Meeting, Scottsdale, Arizona.
2001
Single Nucleotide Polymorphisms Distinguish Multiple Dopamine Transporter
Alleles in Primates
Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
2002 Cloning of rhesus monkey TAR-1, a novel GPCR for “trace” amines
Oral presentation/ selected abstract
Society for Neuroscience Annual Meeting, Orlando, Florida
2003 A Mu-opioid Receptor Single Nucleotide Polymorphism in Rhesus Monkey:
Association With Stress Response And Aggression
Oral presentation/ selected abstract
Society for Neuroscience Annual Meeting, New Orleans, Louisiana
2003 Genetic Variations And Phenotypic Associations Common To Rhesus Monkeys
And Humans
Invited Presentations
Cell Biology of Addiction Course
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
2006 Rhesus monkey Trace Amine Receptor 1
Invited Presentation
Lundbeck Research USA Inc., Mahwah, NJ
2006
Neurobiology and Physiogenetics of Neuropsychiatric
Invited Presentation
NCRR Workshops on the Rhesus Monkey Genome, NIH, Bethesda, MD
2006
Trace amine receptor 1 in Brain Monoaminergic Systems
Invited Presentation
Eli Lilly, Indianapolis, IN
20
2007 Using non-human primates to model the genetics of human neuropsychiatric
Disorders
Invited Presentation
NCRR Workshops on the Rhesus Monkey Genome, NIH, Bethesda, MD
2008
Developing Non-Human Primate Genetic Models of Human Neuropsychiatric and
Addictive Disease
Oral presentation/ selected abstract
Society for Neuroscience Annual Meeting, Washington, DC
2008 Session 314.Stress, depression and monoamines
Session Chair
Society for Neuroscience Annual Meeting, Washington, DC
2008 What are the Roles of Trace Amine Associated Receptor 1 in Primates?
Session Organizer and Invited Presentation
The 41st Winter Conference on Brain Research, Snowbird, UT
2008 Trace Amine-Associated Receptor 1 in Brain Monoaminergic Systems
Selected by the Department of Physiology & Pharmacology Graduate Students as
the annual invited speaker
Oregon Health & Science University
Portland, OR
2008 Monkey Genes Come in Human Flavors: Translational Models of Human
Neuropsychiatric and Substance Abuse Disorders in Rhesus Monkeys
Invited by the APA Committee on Animal Research and Ethics
The 116th Annual Meeting of the American Psychological Association
Boston, MA
2009 Non-Human Primate Genetic Models of Human Neuropsychiatric and Addictive
Disease. The Behavioral Genetics of Co-Morbidity: More Than Just
Overlapping Phenotypes
Invited NIDA-sponsored Presentation
The 42st Winter Conference on Brain Research
Copper Mountain, CO
2009 Trace Amine-Associated Receptor 1 (TAAR1) as a Monoaminergic Modulator
Invited Presentation
Oregon National Primate Research Center, Beaverton, OR
2010 Oral Communications Session 16. Transmitting Information on Serotonin
Session Chair
College on Problems of Drug Dependence Annual Meeting
Scottsdale, Arizona.
21
2011
Advancing the Rhesus Monkey Model for Opioid Research: Discovery of a Novel
Nonsynonymous Variant in the Kappa Opioid Receptor Gene
Oral presentation/ selected abstract
College on Problems of Drug Dependence Annual Meeting
Hollywood, Florida
2011 Oral Communications 2 Genetics: Code Read
Session Chair
College on Problems of Drug Dependence Annual Meeting
Hollywood, Florida
2011 The Biogenic Amine/Amphetamine Receptor TAAR1: What’s It Doing in Brain
Monoaminergic Systems?
Invited Presentation
Department of Physiology
Emory School of Medicine, Atlanta, GA
2013 Trace Amine Associated Receptor 1 in the Monoamine System and its Role in
Modulating the Effects of Drugs of Abuse.
Invited Presentation
Dept. Integrative Physiology and Neuroscience
College of Veterinary Medicine
Washington State University, Pullman, WA
2013
Studies on Trace Amine Associated Receptor 1
Invited Presentation
TMED - Translational Medicine & Early Development
Sunovion Pharmaceuticals Inc.
Marlborough, MA
2013 Trace amine-associated receptor 1 is a methamphetamine receptor that
differentially controls DAT and NET internalization
Invited Presentation
Symposium XIII: New Tools Provide New Insights Into Methamphetamine’s
Actions
College on Problems of Drug Dependence Annual Meeting
San Diego, CA
2013 Trace amine associated receptor 1 modulation of the rewarding and
immunological effects of drugs of abuse supports its relevance as a therapeutic
target.
Invited Speaker
Session Chair
Panel Session 1. Kicking Over the Traces
Noncatecholic Biogenic Amines and Their Receptors
American College of Neuropsychopharmacology
52nd Annual Meeting
Hollywood, Florida
22
2015 TAAR1 And Drugs of Abuse
Invited Plenary Symposium Speaker: 'TAAR1: from chemistry to behavior and its
implications in drug abuse'
Brain, Biology and Chemistry: Translational Research in Addiction
UT Health Science Center
,March 14-15, 2015
San Antonio, TX
2015 Trace Amine Associated Receptor 1 is Implicated in the Central and
Immunological Effects of Drugs of Abuse
Invited Symposium Speaker
American Society for Pharmacology and Experimental Therapeutics Annual
Meeting
Session Chair: EMERGING ROLES OF TRACE AMINE ASSOCIATED
RECEPTOR 1 (TAAR1) IN DRUG ABUSE AND MENTAL DISORDERS
Boston Convention & Exhibition Center
March 29, 2015
Boston, MA
International
2002 Genetic Diversity of Drug Targets in the Brain: Similarities Between Human and
Rhesus Monkey m-Opioid Receptor Variants
Oral presentation/ selected abstract
College on Problems of Drug Dependence
Quebec City
Quebec, Canada
2005 Rhesus monkeys as naturalistic models for deciphering genotype/phenotype
relationships relevant to human neuropsychiatric disorders
Invited Session Speaker
The 2nd International Conference on Primate Genomics & Human Disease
Seattle, Washington.
2008 Comparable functional polymorphisms in rhesus monkeys and human
neuropsychiatric genes
Invited Session Speaker
The 3nd International Conference on Primate Genomics & Human Disease
Seattle, Washington.
2010 Translational Genetic and Pharmacogenomic Modeling of Human
Neuropsychiatric and Drug Addiction Phenotypes
Program Committee Member and Invited Session Speaker
The 4th International Conference on Primate Genomics & Human Disease
Seattle, WA
23
2010 Session 3. Primate Genomics and AIDS
Session Chair
The 4th International Conference on Primate Genomics & Human Disease
Seattle, WA
2010 The TAAR1 Receptor Orchestrates Trace Amine, Common Biogenic Amine and
Psychostimulant effects in Brain Monoaminergic Systems
Invited Presentation
The 14th Biennial International Amine Oxidase Workshop
Edmonton, Alberta, Canada
2011 Exploiting the Parallel Functional Polymorphisms and Pharmacogenomic
Responsivity Between Rhesus Monkeys and Humans for Drug Discovery:
A New Avenue for Preclinical Modeling to Advance Personalized Medicine for
Psychiatric and Addictive Disease.
Target Meeting 1st World Drug Discovery Online Conference
http://www.targetmeeting.com
2012 Session 2. Genomic and Primate Models of Health and Disease
Session Chair
The 5th International Conference on Primate Genomics & Human Disease
Houston, TX
2012 A Systematic Phenotyping Strategy to Transform the Use of Rhesus Monkeys in
Biomedical Research
Invited Session Speaker
The 5th International Conference on Primate Genomics & Human Disease
Houston, TX
2012 Trace Amine Associated Receptor 1 is a Catecholamine Receptor that
Differentially Controls DAT and NET Internalization
Invited Session Speaker
Theme B. Catecholamine Transporter Genetics
The Tenth International Catecholamine Symposium
Pacific Grove, California
2013 Trace Amine Associated Receptor 1 (TAAR1) Signaling Differentially Regulates
Dopamine and Norepinephrine Transporter Internalization
Invited Symposium Speaker
Session: Anatomy and physiology of dopamine systems
Topic: New Mechanisms by Which Trace Amine-Associated Receptors Modulate
Dopamine Neuron Activity
Dopamine 2013
Alghero, Italy
24
Education of Patients and Service to the Community
Activities
2010- 2013 Member, Executive Committee
2013- Member, Board of Directors
Community Connections Outreach on Substance Abuse
Sudbury, Massachusetts
2012 Organizer, “What were you thinking?”
Presentation of the teen brain
Lincoln Sudbury Regional High School
Sudbury, Massachusetts
2015 Invited Speaker
Nu Rho Psi National Honor Society in Neuroscience
Northeastern University Chapter
2015 Invited Speaker
Science Café
Franklin High School Biology Department
Franklin, Massachusetts
25
Scholarship
Peer reviewed publications in print or other media
1. Gibson MJ, Miller GM, Silverman A-J. Pulsatile luteinizing hormone secretion in normal
female mice and hypogonadal female mice with preoptic area implants. Endocrinology
1991;128:965-71.
2. Wu TJ, Segal AZ, Miller GM, Gibson MJ, Silverman A-J. FOS expression in gonadotropin-
releasing hormone neurons: enhancement by steroid treatment and mating. Endocrinology
1992;131:2045-50.
3. Silverman A-J, Roberts JL, Dong KW, Miller GM, Gibson MJ. Intrahypothalamic injection of
a cell line secreting gonadotropin-releasing hormone results in cellular differentiation and reversal
of hypogonadism in mutant mice. Proceedings of the National Academy of Sciences (USA)
1992;89:10668-72. PMCID: PMC50402
4. Miller GM, Silverman A-J, Roberts JL, Dong KW, Gibson MJ. Functional assessment of
intrahypothalamic implants of immortalized gonadotropin-releasing hormone secreting cells in
female hypogonadal mice. Cell Transplantation 1993;2(3):251-7.
5. Miller GM, Gibson MJ. Opioidergic modulation of N-methyl-D,L-aspartic acid (NMA)-
stimulated LH release in young adult but not older male mice. Neuroendocrinology 1994;59:277-
84.
6. Miller GM, Silverman A-J, Gibson MJ. Neuromodulation of transplanted GnRH neurons in
male and female hypogonadal mice with preoptic area brain grafts. Biology of Reproduction
1995;52:572-83.
7. Miller GM, Alexander JM, Bikkal HA, Katznelson L, Zervas NT, Klibanski A. Somatostatin
receptor subtype gene expression in pituitary adenomas. Journal of Clinical Endocrinology and
Metabolism 1995;80:1386-92.
8. Miller GM, Alexander JM, Klibanski A. Gonadotropin-releasing hormone mRNA expression
in gonadotroph tumors and normal human pituitary. Journal of Clinical Endocrinology and
Metabolism 1996;81:80-3.
9. Gibson MJ, Wu TJ, Miller GM, Silverman A-J. What nature's knockout teaches us about GnRH
Activity: Hypogonadal mice and neuronal grafts. Hormones and Behavior 1997;31(3):212-220.
10. Madras BK, Miller GM, Meltzer PC, Brownell A-L, Fischman AJ. Molecular and regional
targets of cocaine in primate brain: liberation from prosaic views. Addiction Biology 2000;5:351-
9.
11 Miller GM, De La Garza R, Novak MA, Madras BK. Single nucleotide polymorphisms
distinguish multiple dopamine transporter alleles in primates: Implications for association with
attention deficit hyperactivity disorder and other neuropsychiatric disorders. Molecular Psychiatry
2001;6:50-8.
26
12 Miller GM, Yatin SM, De La Garza R, Goulet M, Madras BK. Cloning of dopamine,
norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
Molecular Brain Reserach 2001;87(1):124-43.
13 Goulet M, Miller GM, Bendor J, Liu S, Meltzer PC, Madras BK. Non-amines, drugs without
an amine nitrogen, potently block serotonin transport: novel antidepressant candidates? Synapse
2001;42:129-40.
14 Miller GM, Madras BK. Polymorphisms in the 3’-untranslated region of human and monkey
dopamine transporter genes affect reporter gene expression. Molecular Psychiatry 2002;7(1):44-
55.
15 Madras BK, Miller GM, Fischman AJ. The dopamine transporter: Relevance to attention
deficit hyperactivity disorder (ADHD). Behavioral Brain Research 2002;130(1-2):57-63.
16 Yatin SM, Miller GM, Norton C, Madras BK. Dopamine transporter-dependent and –
independent c-fos induction by dopamine transporter substrates and inhibitors. Synapse
2002;45(1):52-65.
17 Madras BK, Fahey MA, Miller GM, De La Garza R, Spealman RD, Meltzer PC, George SR,
O’Dowd BF, Bonad AA, Livni E, Fischman AJ. Non-amine based dopamine transporter (reuptake)
inhibitors retain properties of amine-based progenitors. European Journal of Pharmacology
2003;479:41-51
18 Miller GM, Bendor J, Tiefenbacher S, Yang H, Novak M, Madras BK. A Mu-opioid receptor
single nucleotide polymorphism in rhesus monkey: Association with stress response and
aggression. Molecular Psychiatry 2004;9(1):99-108.
19 Madras BK, Miller GM, Yatin SM. Dopamine and norepinephrine transporter-dependent
immediate early gene production in vitro: new insights into psychostimulant-induced presynaptic
neuroadaptation. Journal of Neuroscience Methods 2005;143(1):69-78.
20 Madras BK, Miller GM, Fischman AJ. The Dopamine Transporter and Attention Deficit
Hyperactivity Disorder (ADHD). Biological Psychiatry 2005;57(11):1397-1409.
21 Jassen AK, Brown JM, Panas HN, Miller GM, Xiao D, Madras BK. Variants of the primate
vesicular monoamine transporter-2. Molecular Brain Research 2005;139(2):251-7.
22 Yatin SM, Miller GM, Madras BK. Dopamine and norepinephrine transporter-dependent c-
Fos production in vitro: relevance to neuroadaptation. Journal of Neuroscience Methods
2005;143(1):69-78. 23. Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R and
Madras BK. Primate trace amine receptor 1 modulation by the dopamine transporter. Journal of
Pharmacology and Experimental Therapeutics 2005;313(3):983-994.
27
24. Xiao D, Miller GM, Jassen AK, Westmoreland SV, Pauley D, Madras BK. Ephrin/Eph
Receptor Expression in Brain of Adult Nonhuman Primates: Implications for Neuroadaption.
Molecular Brain Research, 2006;1067(1):67-77.
25. Jassen AK, Yang H, Miller GM, Calder E, Madras BK. Receptor regulation of axon guidance
molecule gene expression. Molecular Pharmacology 2006;70(1):71-7.
26. Kumar, R, Orsoni1 S, Norman1 L, Tirado1 G, Verma1 AS, Staprans S, Miller G, Buch SJ,
Kumar A. Morphine Addiction Causes Pronounced Virus Replication in Cerebral Compartment
and Accelerated Onset of AIDS in SIV/SHIV-infected Indian Rhesus Macaques. Virology
2006;354(1):192-206.
27. Chen GL, Novak MA, Hakim S, Xie Z, Miller GM. Tryptophan hydroxylase-2 gene
polymorphisms in rhesus monkeys: association with hypothalamic-pituitary-adrenal axis function
and in vitro gene expression. Molecular Psychiatry 2006;11(10):914-28.
28. Madras BK, Xie Z, Lin Z, Jassen AJ, Panas H, Lynch L, Johnson RS, Livni E, Spencer TJ,
Bonab AA, Miller GM, Fischman AJ. Modafinil Occupies Dopamine and Norepinephrine
Transporters in vivo and Modulates the Transporters and Trace Amine Activity in vitro. Journal
of Pharmacology and Experimental Therapeutics 2006;319(2):561-9.
29. Newman RM, Hall L, Connole M, Chen G-l, Sato S, Yuste E, Diehl W, Hunter E, Kaur A,
Miller GM and Johnson WE. Balancing selection and the evolution of functional polymorphism
in old world monkey trim5alpha. Proceeding of the National Academy of Science (USA),
2006;103(50):19134-9. PMCID: PMC1679755
30. Verrico CD, Miller GM, Madras BK. MDMA (Ecstasy) and Human Dopamine,
Norepinephrine and Serotonin Transporters: Implications for MDMA-Induced Neurotoxicity and
Treatment. Psychopharmacology 2007;189(4):489-503.
31. Xie, Z, Westmoreland S, Bahn ME, Chen G-L, Yang H, Vallender E, Yao WD, Madras BK,
Miller GM. Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by
monoamine transporters and attenuation by the D2 autoreceptor in vitro. Journal of Pharmacology
and Experimental Therapeutics 2007;321(1):116-27.
32. Xie Z and Miller GM. Trace Amine-Associated Receptor 1 is a Modulator of the Dopamine
Transporter. Journal of Pharmacology and Experimental Therapeutics 2007;321(1):128-36.
33. Zhang JP, Vinuela A, Neely MH, Grant SG, Miller GM, Isacson O, Caron MG, Yao WD.
Inhibition of the Dopamine D1 Receptor Signaling by PSD-95. Journal of Biological Chemistry.
2007;282(21):15778-89. PMCID: PMC2649122
34. Chen GL and Miller GM. Rhesus Monkey Tryptophan Hydroxylase-2 Coding Region
Haplotypes Affect mRNA Stability. Neuroscience 2008;155(2):485-91. PMCID: PMC2644555
35. Chen G-L, Vallender EJ, Miller GM. Functional Characterization of the Human TPH2 5'
Regulatory Region: Untranslated Region and Polymorphisms Modulate Gene Expression In Vitro.
Human Genetics 2008;122(6):645-57. PMCID: PMC2734478
28
36. Lee AS, Gutierrez-Arcelus M, Perry GH, Vallender EJ, Johnson WE, Miller GM, Korbel JO
and Lee C. Analysis of copy number variation in the rhesus macaque genome identifies candidate
loci for evolutionary and human disease studies. Human Molecular Genetics 2008; 17(8):1127-36.
37. Xie Z and Miller GM. -Phenylethylamine Alters Monoamine Transporter Function via Trace
Amine-Associated Receptor 1: Implication for Modulatory Roles of Trace Amines in Brain.
Journal of Pharmacology and Experimental Therapeutics 2008;325(2):617-628.
38. Xie Z, Westmoreland SV, Miller GM. Modulation of Monoamine Transporters by Common
Biogenic Amines via Trace Amine-Associated Receptor 1 and Monoamine Autoreceptors in
HEK293 Cells and Brain Synaptosomes. Journal of Pharmacology and Experimental Therapeutics
2008;325(2):629-640.
39. Vallender EJ, Priddy CM, Chen G-L, Miller GM. Human Expression Variation in the mu
Opioid Receptor is Paralleled in the Rhesus Macaque. Behavior Genetics 2008;38(4):390-395.
40. Vallender EJ, Priddy CM, Hakim S, Yang H, Chen G-L, Miller GM. Functional variation in
the 3’ UTR of the serotonin transporter in human and rhesus macaque. Genes, Brain and Behavior
2008;7(6):690-7.
41. Xie Z, Vallender EJ, Yu N, Kirstein S, Yang H, Bahn M, Westmoreland SV, Miller GM.
Cloning, expression and functional analysis of rhesus monkey trace amine-associated receptor 6:
Evidence for lack of monoaminergic association. Journal of Neuroscience Research
2008;86(15):3435-46. PMCID: PMC2644554
42. Verrico CD, Lynch L, Fahey MA, Fryer A-K, Miller GM and Madras BK. MDMA-induced
impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a
dopamine/norepinephrine transport inhibitor. Journal of Psychopharmacology 2008;22(2):187-
202.
43. Vallender EJ, Lynch L, Novak MA, Miller GM. Polymorphisms in the 3' UTR of the serotonin
transporter are associated with cognitive flexibility in rhesus macaques. American Journal of
Medical Genetics Part B: Neuropsychiatric Genetics 2009;150B(4):467-75. PMCID:
PMC2702718
44. Chen GL and Miller GM. 5'-Untranslated Region of the Tryptophan hydroxylase-2 Gene
Harbors an Asymmetric Bidirectional Promoter but not Internal Ribosome Entry Site in vitro.
Gene 2009;435(1-2):53-62. PMCID: PMC2670360
45. Xie Z and Miller GM. A Receptor Mechanism for Methamphetamine Action in Dopamine
Transporter Regulation in Brain. Journal of Pharmacology and Experimental Therapeutics
2009;330(1):316-25. PMCID: PMC2700171
46. Ferguson B, Capitanio J, Folks T, Hotchkiss C, Johnson Z, Kean L, Kubisch HM, Lank S,
Lyons L, Miller GM, Nylander J, O'Connor D, Vallender EJ, Wiseman R. Resource brief: the
National Non-Human Primate DNA Bank. Methods. 2009;49(1):3-4. PMCID: PMC3172814
29
47. Kanthaswamy S, Capitanio JP, Dubay CJ, Ferguson B, Folks T, Ha JC, Hotchkiss CE,
Johnson ZP, Katze MG, Kean LS, Kubisch HM, Lank S, Lyons LA, Miller GM, Nylander J,
O’Connor DH, Palermo RE, Smith DG, Vallender EJ, Wiseman RW, Rogers J. Resources for
Genetic Management and Genomics Research on Non-Human Primates at the National Primate
Research Centers (NPRCs). Journal of Medical Primatology 2009;38 Suppl 1:17-23.
48. Xie Z and Miller GM. Trace amine-associated receptor 1 as a monoaminergic modulator in
brain. Biochemical Pharmacology 2009 78(9);1095-04. Review. PMCID: PMC2748138
49. Chen GL, Novak MA, Meyer JS, Kelly BJ, Vallender EJ, Miller GM. The Effect of Rearing
Experience and TPH2 Genotype on HPA Axis Function and Aggression in Rhesus Monkeys: a
Retrospective Analysis. Hormones and Behavior 2010;57(2):184-91. PMCID: PMC2815197
50. Vallender EJ, Ruedi-Bettschen D, Miller GM*, Platt DM. A pharmacogenetic model of
naltrexone-induced attenuation of alcohol consumption in rhesus monkeys. Drug and Alcohol
Dependence 2010;109(1-3):252-6. PMCID: PMC2875311 *Corresponding author
51. Vallender EJ, Xie Z, Westmoreland SV, Miller GM. Functional evolution of the trace amine
associated receptors in mammals and the loss of TAAR1 in dogs. BMC Evolutionary Biology
2010;10:51. PMCID: PMC2838891
52. Chen GL, Novak MA, Meyer JS, Kelly BJ, Vallender EJ, Miller GM. TPH2 5'- and 3'-
Regulatory Polymorphisms Are Differentially Associated with HPA Axis Function and Self-
Injurious Behavior in Rhesus Monkeys. Genes, Brain and Behavior 2010;9(3):335-347. PMCID:
PMC2990963
53. *Panas H, *Lynch L, Vallender E, Xie Z, Chen GL, Lynn S, Scanlan T and Miller GM.
Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like
psychostimulants in trace amine associated receptor 1 knockout mice. Journal of Neuroscience
Research 2010;88(9):1962-9. PMC Journal - In Process *Shared first-authorship; both are Research Assistant III’s in my lab.
54. Miller GM. The Emerging Role of Trace Amine Associated Receptor 1 in the Functional
Regulation of Monoamine Transporters and Dopaminergic Activity. Journal of Neurochemistry
2011;116(2):164-76. PMCID: PMC3005101 Review, contains new data not published elsewhere.
55. Karmacharya R, Lynn SK, Demarco S, Ortiz A, Wang X, Lundy MY, Xie Z,
Cohen BM, Miller GM, Buttner EA. Behavioral effects of clozapine: Involvement of trace
amine pathways in C. elegans and M. musculus. Brain Research 2011, Jun 1;1393:91-9. PMCID:
PMC3107707
56. Westmoreland SV, Annamalai L, Lentz MR, Ratai EM, Assaf B, Boisvert K, Huynh T,
Vallender EJ, Miller GM, Madras BK, Gonzalez RG. Growth associated protein-43 and Ephrin
B3 Induction in the Brain of Adult SIV-infected Rhesus Macaques. Journal of Neurovirology.
2011. In press. PMC Journal - In Process
30
57. Lewin AH, Miller GM, Gilmour B. Trace amine-associated receptor 1 is a stereoselective
binding site for compounds in the amphetamine class. Bioorganic & Medicinal Chemistry Dec
1;19(23):7044-8, 2011. PMCID: PMC3236098
58. Achat-Mendes C, Lynch LJ, Sullivan KA, Vallender EJ, Miller GM. Augmentation of
methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated
receptor 1. Pharmacol Biochem Behav. Apr;101(2):201-207, 2012. PMCID: PMC3288391
59. Chen G-L and Miller GM. Advances in Tryptophan Hydroxylase-2 Gene Expression
Regulation: New Insights into Serotonin-Stress Interaction and Clinical Implications. American
Journal of Medical Genetics Part B: Neuropsychiatric Genetics. Mar;159B(2):152-171, 2012
PMC Journal - In Process
60. Miller GM. Avenues for the Development of Therapeutics That Target Trace Amine
Associated Receptor 1 (TAAR1). Journal of Medicinal Chemistry, Mar 8;55(5):1809-1814,
2012. PMCID: PMC3618978
61. Panas MW, Xie Z, Panas HN, Hoener MC, Vallender EJ, Miller GM. Trace Amine
Associated Receptor 1 Signaling in Activated Lymphocytes. Journal of Neuroimmune
Pharmacology Dec;7(4):866-76, 2012 PMC Journal - In Process
62. Chen GL, Miller GM. Tryptophan Hydroxylase-2: An Emerging Therapeutic Target for
Stress Disorders. Biochem Pharmacol. 2013 Feb 19 [Epub ahead of print], In press.
63. Chen GL, Miller GM. Extensive Alternative Splicing of the Repressor Element Silencing
Transcription Factor Linked to Cancer. PLOSOne 2013 Apr 16;8(4):e62217. PMCID:
PMC3628349
64. Lynch J*, Sullivan KA*, Vallender EJ, Rowlett JK, Platt DM, Miller GM. Trace Amine
Associated Receptor 1 Modulates Behavioral Effects of Ethanol. Substance Abuse: Research and
Treatment. 2013, Jun 4;7:117-126. PMC Journal - In Process * both are Research Assistant III’s in my lab.
65. Vallender EJ and Miller GM. Non-Human Primate Models in the Genomic Era: A Paradigm
Shift. Institute for Laboratory Animal Research Journal 2013 54: 154-165.
66. Dharmendra B Goswami DB, Ogawa LM, Ward JM, Miller GM, Vallender EJ. Large-scale
polymorphism discovery in macaque G-protein coupled receptors. BMC Genomics 2013,
14:703. PMC Journal - In Process
67. Cho JA, Zhang X, Miller GM, Lencer WI, Nery FC. 4-phenylbutyrate attenuates the ER Stress
Response and Decreases Cyclic AMP Accumulation in DYT1 Dystonia Cell Models. PLOSOne
2014, Nov 7;9(11):e110086
68. Yasuda K, Oh K, Ren B, Tickle TL, Franzosa EA., Wachtman LM., Miller AD,
Westmoreland SV, Mansfield KG, Vallender EJ, Miller GM, Rowlett JK., Gevers D,
Huttenhower C. Morgan XC. Biogeography of the intestinal mucosal and lumenal microbiome in
the rhesus macaque. In press. Cell Host and Microbe 2015, 17(3):385-91.
31
Non-peer reviewed scientific or medical publications/materials in print or other media
1. Madras B, Miller GM, De La Garza R, Dougherty DD, Bonab AA, Spencer TJ, Rauch SL,
Fischman AJ. Brain Imaging of the dopamine transporter in ADHD. 6th International World
Congress for Biomedical.Sciences 2000;113. PMC Journal - In Process
2. Gibson MJ, Saitoh Y, Miller GM, Silverman A-J. Functional GnRH neuronal transplants in the
hypogonadal mouse. In: Crowley WF Jr, Conn PM, editors. Modes of Action of GnRH and GnRH
analogs. New York, New York: Springer-Verlag, 1992:144-57.
3. Miller GM, Zhang X, Klibanski A. Pituitary tumors: future perspectives. In: Kovacs, K. editors.
Diagnosis and management of pituitary tumors. Totowa, New Jersey: Humana Press Inc., 2001,
pgs 462-6.
4. Miller GM and Madras BK. Genetic Variations and Phenotypic Associations Common to
Rhesus Monkeys and Humans. In: SA Wolfe-Coote, editor. The Laboratory Primate. Tygerberg,
South Africa: Medical Research Council of South Africa, Elsevier Publishing Inc., 2005.
5. Ferguson B, Miller GM. Genetic tools for understanding the primate genome. Methods
2009;49(1):1-2. Editorial.
Thesis
1. Miller GM. Neuromodulation of luteinizing hormone secretion in the mouse [dissertation]. New
York (NY): City Univ. New York, 1993.